X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (658) 658
child (430) 430
male (423) 423
female (417) 417
rhabdomyosarcoma (407) 407
child, preschool (364) 364
adolescent (328) 328
index medicus (320) 320
oncology (307) 307
infant (286) 286
rhabdomyosarcoma - mortality (258) 258
pediatrics (239) 239
children (204) 204
prognosis (202) 202
rhabdomyosarcoma - pathology (191) 191
adult (188) 188
rhabdomyosarcoma - therapy (179) 179
cancer (177) 177
intergroup rhabdomyosarcoma (168) 168
chemotherapy (160) 160
retrospective studies (146) 146
surgery (145) 145
sarcoma (140) 140
tumors (140) 140
combined modality therapy (128) 128
survival rate (128) 128
treatment outcome (114) 114
radiotherapy (99) 99
childhood (96) 96
neoplasm staging (96) 96
rhabdomyosarcoma - surgery (94) 94
antineoplastic combined chemotherapy protocols - therapeutic use (93) 93
embryonal rhabdomyosarcoma (92) 92
disease-free survival (90) 90
hematology (89) 89
infant, newborn (85) 85
follow-up studies (83) 83
rhabdomyosarcoma - drug therapy (82) 82
alveolar rhabdomyosarcoma (75) 75
rhabdomyosarcoma - diagnosis (75) 75
care and treatment (72) 72
middle aged (72) 72
survival analysis (72) 72
young adult (72) 72
diagnosis (66) 66
soft-tissue sarcoma (66) 66
pathology (63) 63
analysis (61) 61
metastasis (61) 61
survival (61) 61
age factors (60) 60
research (57) 57
rhabdomyosarcoma - radiotherapy (57) 57
aged (56) 56
patients (54) 54
therapy (52) 52
childhood rhabdomyosarcoma (51) 51
rhabdomyosarcoma, embryonal - mortality (51) 51
radiology, nuclear medicine & medical imaging (50) 50
time factors (49) 49
animals (47) 47
health aspects (47) 47
rhabdomyosarcoma - genetics (47) 47
rhabdomyosarcoma, alveolar - pathology (47) 47
risk factors (47) 47
childrens oncology group (46) 46
immunohistochemistry (45) 45
sarcoma - mortality (45) 45
sarcoma - pathology (45) 45
medical prognosis (44) 44
neoplasm metastasis (44) 44
soft-tissue sarcomas (43) 43
expression (42) 42
prognostic-factors (42) 42
neoplasm recurrence, local (41) 41
sarcoma - therapy (41) 41
soft tissue neoplasms - pathology (41) 41
adolescents (40) 40
article (40) 40
medicine & public health (40) 40
rhabdomyosarcoma, alveolar - mortality (40) 40
experience (39) 39
pediatric (39) 39
radiation therapy (38) 38
rhabdomyosarcoma, embryonal - pathology (38) 38
diagnosis, differential (36) 36
head (36) 36
hematology, oncology and palliative medicine (36) 36
soft tissue neoplasms - mortality (36) 36
kaplan-meier estimate (35) 35
management (35) 35
neuroblastoma (35) 35
urology & nephrology (34) 34
age (33) 33
head and neck neoplasms - mortality (33) 33
radiotherapy dosage (33) 33
adolescence (32) 32
neoplasms (31) 31
radiation (31) 31
sarcomas (31) 31
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (776) 776
German (3) 3
Chinese (2) 2
Japanese (2) 2
Spanish (2) 2
French (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 13, pp. 2151 - 2158
Journal Article
Cancer Cell, ISSN 1535-6108, 08/2014, Volume 26, Issue 2, pp. 273 - 287
Journal Article
Journal Article
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 49, Issue 16, pp. 3462 - 3470
Abstract Background Rhabdomyosarcoma (RMS) is an aggressive soft tissue tumour mainly affecting children and adolescents. Since survival of high-risk patients... 
Hematology, Oncology and Palliative Medicine | Anaplastic lymphoma kinase receptor | Insulin-like growth factor 1 receptor | Embryonal rhabdomyosarcoma | Targeted treatment | In vitro | Alveolar rhabdomyosarcoma | METASTATIC RHABDOMYOSARCOMA | MONOCLONAL-ANTIBODY | MECHANISMS | COMBINATION | ONCOLOGY | RESISTANCE | INTERGROUP | OUTCOMES | INHIBITOR | IGF-1 RECEPTOR | EXPRESSION | Receptor, IGF Type 1 - metabolism | Receptor, IGF Type 1 - antagonists & inhibitors | Humans | Middle Aged | Child, Preschool | Infant | Molecular Targeted Therapy | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Young Adult | Netherlands | Rhabdomyosarcoma, Alveolar - mortality | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Rhabdomyosarcoma, Alveolar - pathology | Child | Infant, Newborn | Rhabdomyosarcoma, Embryonal - pathology | Rhabdomyosarcoma, Alveolar - drug therapy | Cell Survival - drug effects | Rhabdomyosarcoma, Embryonal - enzymology | Kaplan-Meier Estimate | Rhabdomyosarcoma, Embryonal - mortality | Rhabdomyosarcoma, Embryonal - drug therapy | Chi-Square Distribution | Receptor Protein-Tyrosine Kinases - metabolism | Drug Synergism | Rhabdomyosarcoma, Alveolar - enzymology | Adolescent | Cell Line, Tumor | Aged | Protein Kinase Inhibitors - pharmacology | Lymphomas
Journal Article
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 04/2017, Volume 64, Issue 4, p. n/a
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 2, pp. 635 - 642
Purpose To report the clinical outcome and late side effect profile of proton radiotherapy in the treatment of children with parameningeal rhabdomyosarcoma... 
Radiology | Hematology, Oncology and Palliative Medicine | Conformal radiotherapy | Late effects | Proton radiotherapy | Parameningeal rhabdomyosarcoma | Pediatric | NECK RHABDOMYOSARCOMA | HEAD | INTERGROUP RHABDOMYOSARCOMA | INTERNATIONAL-SOCIETY | INTENSITY-MODULATED RADIOTHERAPY | NONMETASTATIC RHABDOMYOSARCOMA | SOFT-TISSUE | CHILDREN | CHILDHOOD-CANCER | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PEDIATRIC-ONCOLOGY | Follow-Up Studies | Protons - adverse effects | Humans | Child, Preschool | Protons - therapeutic use | Infant | Male | Radiotherapy - adverse effects | Organ Sparing Treatments - methods | Rhabdomyosarcoma - radiotherapy | Meningeal Neoplasms - drug therapy | Rhabdomyosarcoma, Alveolar - mortality | Massachusetts | Female | Rhabdomyosarcoma - drug therapy | Child | Rhabdomyosarcoma - mortality | Rhabdomyosarcoma, Alveolar - drug therapy | Rhabdomyosarcoma, Alveolar - radiotherapy | Treatment Outcome | Rhabdomyosarcoma, Embryonal - mortality | Rhabdomyosarcoma, Embryonal - drug therapy | Meningeal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Meningeal Neoplasms - radiotherapy | Rhabdomyosarcoma, Embryonal - radiotherapy | Radiotherapy | Medical colleges | Nuclear radiation | DIAGNOSIS | PATIENTS | NEOPLASMS | FAILURES | PHOTONS | TEETH | RADIATION DOSES | CARIES | HISTOLOGY | PROTONS | SINUSES | MEDICAL RECORDS | NOSE | RADIATION DOSE UNITS | RADIOLOGY AND NUCLEAR MEDICINE | PEDIATRICS | RADIOTHERAPY | SIDE EFFECTS | COBALT | CONTROL
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 5, pp. 1070 - 1077
Journal Article
International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 04/2012, Volume 82, Issue 5, pp. 1764 - 1770
Purpose: To compare the dosimetric parameters of intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3D-CRT) in patients with... 
Intensity-modulated radiotherapy | 3D-CRT | IMRT | Three-dimensional conformal radiotherapy | Rhabdomyosarcoma | Intermediate risk | TISSUE | CANCER | RADIATION-THERAPY | TRIAL | ONCOLOGY | NECK-RHABDOMYOSARCOMA | CARCINOMA | SURVIVORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Organs at Risk - radiation effects | Humans | Rhabdomyosarcoma - pathology | Male | Radiotherapy, Intensity-Modulated - adverse effects | Rhabdomyosarcoma - radiotherapy | Rhabdomyosarcoma, Alveolar - mortality | Treatment Failure | Sarcoma - mortality | Female | Rhabdomyosarcoma - drug therapy | Rhabdomyosarcoma, Alveolar - pathology | Child | Rhabdomyosarcoma - mortality | Sarcoma - radiotherapy | Rhabdomyosarcoma, Embryonal - pathology | Radiotherapy, Intensity-Modulated - mortality | Rhabdomyosarcoma, Alveolar - drug therapy | Radiotherapy, Intensity-Modulated - methods | Rhabdomyosarcoma, Alveolar - radiotherapy | Rhabdomyosarcoma, Embryonal - mortality | Rhabdomyosarcoma, Embryonal - drug therapy | Sarcoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Epidemiologic Methods | Radiotherapy, Conformal - mortality | Radiotherapy, Conformal - adverse effects | Rhabdomyosarcoma, Embryonal - radiotherapy | Radiotherapy, Conformal - methods | Nuclear radiation | Analysis | Radiation | Medical care | Universities and colleges | Radiotherapy | Methods | Quality management | Index Medicus | PATIENTS | NEOPLASMS | INTEGRAL DOSES | FAILURES | TOXICITY | COMPARATIVE EVALUATIONS | CHILDREN | PLANNING | MULTIVARIATE ANALYSIS | RADIOLOGY AND NUCLEAR MEDICINE | REGRESSION ANALYSIS | RADIOTHERAPY | CONTROL | HAZARDS
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 10/2014, Volume 21, Issue 11, pp. 3579 - 3586
Journal Article